Your browser doesn't support javascript.
loading
Treatment of CD19-positive mixed phenotype acute leukemia with blinatumomab.
El Chaer, Firas; Ali, Omer M; Sausville, Edward A; Law, Jennie Y; Lee, Seung Tae; Duong, Vu H; Baer, Maria R; Koka, Rima; Singh, Zeba N; Wong, Jerry; Yared, Jean A; Griffiths, Elizabeth A; Emadi, Ashkan.
Afiliação
  • El Chaer F; Departments of Medicine, University of Maryland School of Medicine, Baltimore, Maryland.
  • Ali OM; University of Maryland Greenebaum Comprehensive Cancer Center Baltimore, Baltimore, Maryland.
  • Sausville EA; Departments of Medicine, University of Maryland School of Medicine, Baltimore, Maryland.
  • Law JY; Departments of Medicine, University of Maryland School of Medicine, Baltimore, Maryland.
  • Lee ST; University of Maryland Greenebaum Comprehensive Cancer Center Baltimore, Baltimore, Maryland.
  • Duong VH; Departments of Medicine, University of Maryland School of Medicine, Baltimore, Maryland.
  • Baer MR; University of Maryland Greenebaum Comprehensive Cancer Center Baltimore, Baltimore, Maryland.
  • Koka R; Departments of Medicine, University of Maryland School of Medicine, Baltimore, Maryland.
  • Singh ZN; University of Maryland Greenebaum Comprehensive Cancer Center Baltimore, Baltimore, Maryland.
  • Wong J; Departments of Medicine, University of Maryland School of Medicine, Baltimore, Maryland.
  • Yared JA; University of Maryland Greenebaum Comprehensive Cancer Center Baltimore, Baltimore, Maryland.
  • Griffiths EA; Departments of Medicine, University of Maryland School of Medicine, Baltimore, Maryland.
  • Emadi A; Departments of Pathology, University of Maryland School of Medicine, Baltimore, Maryland.
Am J Hematol ; 94(1): E7-E8, 2019 01.
Article em En | MEDLINE | ID: mdl-30328137

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Aguda Bifenotípica / Anticorpos Biespecíficos / Antígenos CD19 / Terapia de Alvo Molecular / Antineoplásicos Imunológicos Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Aguda Bifenotípica / Anticorpos Biespecíficos / Antígenos CD19 / Terapia de Alvo Molecular / Antineoplásicos Imunológicos Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Ano de publicação: 2019 Tipo de documento: Article